Nexthera Capital »

Abbvie shares owned by Nexthera Capital

Quarter-by-quarter ownership of Abbvie (ABBV) shares owned by Nexthera Capital from 13F filings

Historical chart of Nexthera Capital investment in Abbvie

Jan 2016Jul 2016Jan 2017Jul 2017Jan 2018Jul 2018Jan 2019Jul 20193.65M3.7M3.75M3.8M52k54k56k58k60k62k
Value ($)Share countHistorical ABBV position of Nexthera Capital Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Abbvie held by Nexthera Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abbvie by Nexthera Capital

Quarter filed Position value Share count Share price at filing
2019-06-30 $3.8M 53k 72.72
2015-12-31 $3.6M 62k 59.24

More positions owned by Nexthera Capital

Intercept Pharmaceuticals In
Insmed (INSM)
Audentes Therapeutics
Neurocrine Biosciences (NBIX)
Sarepta Therapeutics (SRPT)
Global Blood Therapeutics In
Immunomedics
Coherus Biosciences (CHRS)
Ascendis Pharma A S (ASND)
Pacira Pharmaceuticals (PCRX)
Urogen Pharma (URGN)
Uniqure Nv (QURE)
Amarin Corporation (AMRN)
Abbvie (ABBV)
Biohaven Pharmaceutical Holding

View all positions for Nexthera Capital

Top funds holding Abbvie

Vanguard Group
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Morgan Stanley
Geode Capital Management
Capital Research Global Investors
Capital Research and Management Company - Division 3
Charles Schwab Investment Management
Bank of America Corporation
Norges Bank Investment Management
Northern Trust
FMR
Franklin Resources
Capital World Investors

View all funds holding Abbvie